Panel: The Digitized Patient Experience: How Novel Digital Therapeutics (DTx) Data Will Reshape Your Analytics and Remote Patient Care Programs

Chris Hogg, MBA - Chief Commercial Officer, Propeller Health
Carlos Rodarte - Life Sciences Strategy Business Development, Health Catalyst
Eddie Martucci, PhD - Chief Executive Officer, Akili
Mette Dyhrberg - CEO, Mymee Inc.
Owen McCarthy, MBA - Co-founder and President, MedRhythmns, Inc.

Digital Therapeutics (DTx), defined as software-driven evidence-based therapeutic medical interventions, are used increasingly for conditions not well-addressed by mainstream medicine. These therapies collect information on a new frontier: a patient’s moment-by-moment physiological processes, emotions, behaviors, and environment. How should these highly personalized tools be implemented? How should this flood of data be governed and analyzed? How will the increased information affect the provider’s role? A panel of DTx developers will address these questions and more.